By a
“Brad is a great addition to our team and brings the strong financial and business expertise that Homology Medicines will leverage as we continue to move our lead gene therapy and gene editing programs forward toward the clinic,” said
Prior to joining Homology Medicines,
“What attracted me to Homology Medicines is the proprietary gene editing and gene therapy technology platform that utilizes homologous recombination, a naturally occurring biological mechanism, and an executive team with demonstrated success in turning scientific concepts into treatments for patients with rare genetic diseases,” said
Keywords for this news article include: Biotechnology, Genetics, Gene Therapy, Bioengineering, Drugs and Therapies, Investment and Finance,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
More Pittsburghers eligible for loans to replace lead water lines
FORESTAR ALERT: J&W Launches an Investigation into the Proposed Sale of Forestar Group Inc.; Are Shareholders Getting a Fair Price?
More Articles